oYo-Link[R] VcMMAF Antibody Labeling Reagent

Size

£521.00

SKU:: AT7003
Application:: FuncS
Concentration:: 270 ug/ml
Physical State:: Dried pellet
Molecular Weight:: 8 kDa
Storage Conditions:: 2-8[o]C, -70[o]C Avoid freeze/thaw cycles.
Supplier:: AlphaThera
ABP:: No Import Docs
Buffer:: PBS
Extra Details:: Research Use Only Application: Antibody conjugation Reagent for Targeted cell death; Targeted cell death for cancer cells; High-throughput screening with cell killing assays oYo-Link® VcMMAF is an Antibody-Drug Conjugation Reagent allowing for site-specific labeling of Monomethyl Auristatin F. labels to the heavy-chains of oYo-Link®-compatible antibodies with up to two labels per antibody. VcMMAF is an anti-mitotic agent linked via the lysosomally cleavable dipeptide, valine-citrulline (vc). oYo-Link® limits the attachment of the VcMMAF drugs to the heavy chains of the antibody and therefore ensures that the drug label does not interfere with antibody binding. Furthermore, site-specific labeling limits 1-2 VcMMAF drugs to be attached per antibody, providing precise antibody-drug conjugate ratios. The antibody labeling procedure simply requires mixing oYo-Link® VcMMAF with the desired antibody followed by photocrosslinking with non-damaging black light (365 nm). Photocrosslinking can be carried in most buffers, including those containing amine-containing molecules (e.g. TRIS, glycine) or storage proteins (see Buffer Compatibility Table). Catalog # AT7003 Requirements: To label your compatible antibodies with oYo-Link®, you will need a Light Source emitting at 365nm (6-10W). Use your own Compatible Device from our list or purchase AlphaThera's LED Photo-Crosslinking Device. Technical Support: For science questions or questions concerning compatibility email [email protected]

Shipping Conditions:: Ambient